Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: A pilot study

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 11, 2011, Pages 3374-3380

  Bogazzi, Fausto ^a   Bartalena, Luigi ^b   Tomisti, Luca ^a   Rossi, Giuseppe ^c   Brogioni, Sandra ^a   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; LEVOTHYROXINE; LIOTHYRONINE; PREDNISONE; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EUTHYROIDISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA; THYROIDECTOMY; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TYPE 2 AMIODARONE INDUCED THYROTOXICOSIS;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; COHORT STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PREDNISONE; RETROSPECTIVE STUDIES; THYROTOXICOSIS; TREATMENT OUTCOME;

EID: 80655147352     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1678     Document Type: Article

References (22)

1. Bogazzi F, Bartalena L, Martino E 2010 Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95:2529-2535
2. Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A, Martino E 2007 Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin Endocrinol (Oxf) 67:533-537 (Pubitemid 47416310)
3. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240-254 (Pubitemid 32458161)
4. Eskes SA, Wiersinga WM 2009 Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 23:735-751
5. Cohen-Lehman J, Dahl P, Danzi S, Klein I 2010 Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol 6:34 -41
6. Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM 2002 Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 56:33-38 (Pubitemid 34107319)
7. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E 1997 Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 7:541-545 (Pubitemid 27371790)
8. Bogazzi F, Tomisti L, Rossi G, Dell'Unto E, Pepe P, Bartalena L, Martino E 2009 Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. J Clin Endocrinol Metab 94:3757-3762
9. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E 2004 Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61:494-502 (Pubitemid 39388489)
10. Diehl LA, Romaldini JH, Graf H, Bartalena L, Martino E, Albino CC, Wiersinga WM 2006 Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clin Endocrinol (Oxf) 65:433-438 (Pubitemid 44414265)
11. Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L 2008 Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf) 69:812-818
12. Tanda ML, Bogazzi F, Martino E, Bartalena L 2008 Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? Eur J Endocrinol 159:359-361
13. Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell'Unto E, Aghini-Lombardi F, Martino E 2007 Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab 92:556-562
14. Yiu KH, Jim MH, Siu CW, Lee CH, Yuen M, Mok M, Shea YF, Fan K, Tse HF, Chow WH 2009 Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. J Clin Endocrinol Metab 94:109-114
15. Osman F, Franklyn JA, Sheppard MC, Gammage MD 2002 Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 105:1275-1277 (Pubitemid 34260414)
16. Uzan L, Guignat L, Meune C, Mouly S, Weber S, Bertagna X, Bertherat J, Thomopoulos P, Duboc D 2006 Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis. Drug Saf 29:231-236 (Pubitemid 43363835)
17. Mosteller RD 1987 Simplified calculation of body-surface area. N Engl J Med 317:1098
18. Fiore E, Rago T, Scutari M, Ugolini C, Proietti A, Di Coscio G, Provenzale MA, Berti P, Grasso L, Mariotti S, Pinchera A, Vitti P 2009 Papillary thyroid cancer, although strongly associated with lymphocitic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. J Endocr Invest 32:344-351
19. Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell'Unto E, Grasso L, Aghini-Lombardi F, Rossi G, Pinchera A, Braverman LE, Martino E 2003 Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab 88:1999-2002 (Pubitemid 36549867)
20. Farwell AP, Abend SL, Huang SK, Patwardhan NA, Braverman LE 1990 Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 263:1526-1528 (Pubitemid 20099048)
21. Franzese CB, Fan CY, Stack Jr BC 2003 Surgical management of amiodarone-induced thyrotoxicosis. Otolaryngol Head Neck Surg 129:565-570 (Pubitemid 37377588)
22. Bogazzi F, Miccoli P, Berti P, Cosci C, Brogioni S, Aghini-Lombardi F, Materazzi G, Bartalena L, Pinchera A, Braverman LE, Martino E 2002 Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 132:1114-1117; discussion 1118